HOMA-IR z-scores were associated with increased risks for incident lung disease, interstitial lung abnormalities, and ...

The phase III A DUE trial showed significantly greater pulmonary vascular resistance improvements with the fixed-dose ...

Tuberculosis remains a public health crisis. The World Health Organization's Global Tuberculosis Report released in November ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – tiakis ...

In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.